A detailed history of Act Capital Management, LLC transactions in Champions Oncology, Inc. stock. As of the latest transaction made, Act Capital Management, LLC holds 62,500 shares of CSBR stock, worth $284,375. This represents 0.65% of its overall portfolio holdings.

Number of Shares
62,500
Previous 62,500 -0.0%
Holding current value
$284,375
Previous $500,000 6.2%
% of portfolio
0.65%
Previous 0.7%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 03, 2022

BUY
$7.76 - $10.23 $31,040 - $40,920
4,000 Added 6.84%
62,500 $523,000
Q3 2021

Nov 16, 2021

BUY
$9.11 - $10.96 $77,435 - $93,160
8,500 Added 17.0%
58,500 $597,000
Q2 2021

Aug 16, 2021

BUY
$8.45 - $11.72 $422,499 - $586,000
50,000 New
50,000 $514,000

Others Institutions Holding CSBR

About CHAMPIONS ONCOLOGY, INC.


  • Ticker CSBR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 13,522,400
  • Market Cap $61.5M
  • Description
  • Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company, through its Tumorgraft Techn...
More about CSBR
Track This Portfolio

Track Act Capital Management, LLC Portfolio

Follow Act Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Act Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Act Capital Management, LLC with notifications on news.